Estatísticas para PMS38 TOFACITINIB FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE ACTIVE PSORIATIC ARTHRITIS INTOLERANT OR WITH THERAPEUTIC FAILURE TO SYNTHETIC OR BIOLOGICAL DISEASE- MODIFYING DRUGS

Total visits

views
PMS38 TOFACITINIB FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE ACTIVE PSORIATIC ARTHRITIS INTOLERANT OR WITH THERAPEUTIC FAILURE TO SYNTHETIC OR BIOLOGICAL DISEASE- MODIFYING DRUGS 0